» Articles » PMID: 34446793

Identification of Key Proteins in the Signaling Crossroads Between Wound Healing and Cancer Hallmark Phenotypes

Overview
Journal Sci Rep
Specialty Science
Date 2021 Aug 27
PMID 34446793
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Wound healing (WH) and cancer seem to share common cellular and molecular processes that could work in a tight balance to maintain tissue homeostasis or, when unregulated, drive tumor progression. The "Cancer Hallmarks" comprise crucial biological properties that mediate the advancement of the disease and affect patient prognosis. These hallmarks have been proposed to overlap with essential features of the WH process. However, common hallmarks and proteins actively participating in both processes have yet to be described. In this work we identify 21 WH proteins strongly linked with solid tumors by integrated TCGA Pan-Cancer and multi-omics analyses. These proteins were associated with eight of the ten described cancer hallmarks, especially avoiding immune destruction. These results show that WH and cancer's common proteins are involved in the microenvironment modification of solid tissues and immune system regulation. This set of proteins, between WH and cancer, could represent key targets for developing therapies.

Citing Articles

The paradoxical activity of BRAF inhibitors: potential use in wound healing.

Karhana S, Samim M, Nidhi , Khan M Arch Dermatol Res. 2025; 317(1):311.

PMID: 39873776 DOI: 10.1007/s00403-024-03785-5.


Dietary Macronutrient Composition and Risk of Radiation-Induced Acute Skin Toxicity in Women with Breast Cancer: Results from the ATHENA Project.

Sharma S, Bracone F, Di Castelnuovo A, Ruggiero E, De Curtis A, Deodato F Nutrients. 2025; 17(1.

PMID: 39796571 PMC: 11722651. DOI: 10.3390/nu17010136.


In Silico Insights Reveal Fibronectin 1 as a Theranostic Marker in Gastric Cancer.

Millapan T, Gutierrez A, Rosas K, Buchegger K, Ili C, Brebi P Int J Mol Sci. 2024; 25(20).

PMID: 39456895 PMC: 11507984. DOI: 10.3390/ijms252011113.


Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies.

Echeverria-Garces G, Ramos-Medina M, Gonzalez A, Vargas R, Cabrera-Andrade A, Armendariz-Castillo I Heliyon. 2024; 10(17):e37488.

PMID: 39296198 PMC: 11409134. DOI: 10.1016/j.heliyon.2024.e37488.


Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.

Lopez-Cortes A, Cabrera-Andrade A, Echeverria-Garces G, Echeverria-Espinoza P, Pineda-Alban M, Elsitdie N Sci Rep. 2024; 14(1):19359.

PMID: 39169044 PMC: 11339426. DOI: 10.1038/s41598-024-68565-7.


References
1.
Zhang L, Zhou W, Velculescu V, Kern S, Hruban R, Hamilton S . Gene expression profiles in normal and cancer cells. Science. 1997; 276(5316):1268-72. DOI: 10.1126/science.276.5316.1268. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Bastiaens P . Systems biology: When it is time to die. Nature. 2009; 459(7245):334-5. DOI: 10.1038/459334a. View

4.
Dvorak H . Tumors: wounds that do not heal-redux. Cancer Immunol Res. 2015; 3(1):1-11. PMC: 4288010. DOI: 10.1158/2326-6066.CIR-14-0209. View

5.
Haddow A . Addendum to "molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing"?. Adv Cancer Res. 1974; 20:343-66. DOI: 10.1016/s0065-230x(08)60113-x. View